Perlegen | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Perlegen

An SI Board Since December 2005

Posts	SubjectMarks	Bans	Symbol
27	10	0	AFFX

Emcee: Mike McFarland	Type: Unmoderated

Introduction Market Data Compact

Perlegen raised 74m in a fourth round
of VC funding in March 2005.

perlegen.com

An article on bioitworld awhile back suggested
competitors might include Solexa, 454, US Genomics,
ParAllele, others. Solexa is publicly traded, and
Yahoo shows AFFX, CRA, and GLGC as competitors.

Until an IPO, I'll just show AFFX for the ticker.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
27	Perlegen Ceases Operations genomeweb.com	CrazyPete	-	1/7/2010
26	Agile ‘NewPharmaCos’ pgxreporter.com <i> Walser said his company is not f	Mike McFarland	-	5/24/2008
25	March 18, 2008 Perlegen Gains Exclusive Access to Data on Four Million Patients	Mike McFarland	-	4/28/2008
24	Perlegen and SC Liver Research Consortium to Collaborate on Interferon Response	Mike McFarland	-	2/25/2008
23	Relatives of Patients With PD at Higher Risk for Depression, Anxiety medscape.co	Mike McFarland	-	12/13/2007
22	three PR in past month: Perlegen’s Contribution to Phase 2 Hapmap of Human Gene	Mike McFarland	-	10/28/2007
21	Perlegen Seeking Genes Responsible perlegen.com	Mike McFarland	-	6/25/2007
20	Kelly Frazer is now director of genomic biology at Scripps Genomic Medicine Prog	Mike McFarland	-	4/8/2007
19	Mark McCamish is now senior vice president and chief medical officer at PDLI. H	Mike McFarland	-	3/23/2007
18	another article, has several paragraphs about Genizon Human Genome-Wide Associa	Mike McFarland	-	1/27/2007
17	NIH Launches dbGaP, a Database of Genome Wide Association Studies The National	Mike McFarland	-	1/4/2007
16	Pfizer had an option to buy $25 million more of Perlegen--had there been an IPO	Mike McFarland	-	1/3/2007
15	Perspectives on development of a combination pharmacogenomic diagnostic and drug	Mike McFarland	-	1/3/2007
14	The HapMap Gold Rush: Researchers Mine a Rich Deposit Jennifer Couzin sciencemag	Mike McFarland	-	5/27/2006
13	The competitor paragraph from the Illumina annual report follows--this may be ap	Mike McFarland	-	5/2/2006
12	<the current market for biotech IPO’s has been brutal> Maybe they should h	Mike McFarland	-	5/2/2006
11	A bearish view from a blog: Perlegen Sciences (PERL) is another player in this	dr.praveen	-	4/28/2006
10	Cool - thanks.	nigel bates	-	4/12/2006
9	Personal Medicine’s Rosy Picture TODAY \| Bio-IT World \| GlaxoSmithKline’s head	Mike McFarland	-	4/11/2006
8	I guess I sorta glossed over and don't really comprehend the difference betw	Mike McFarland	-	4/11/2006
7	I'm drawn to this type of company like a moth to a lantern. We all want to b	Mike McFarland	-	4/11/2006
6	Hi Mike, Thanks for starting the board. I am excited to see perlegen IPO and I	dr.praveen	-	4/10/2006
5	Perlegen Forms Collaboration with Genentech in Cancer Genetics perlegen.com	Mike McFarland	-	1/6/2006
4	Don't you think if Pfizer is willing to plop down $50M in this latest round	Mike McFarland	-	1/5/2006
3	Somebody please tell me something good about this company?	thelaw	-	1/5/2006

Go to reply# or date (mm/dd/yy):